Pertussis Vaccine Research

Kapasi A, Meade BD, Plikaytis B, Pawloski L, Martin MD, Yoder S, Rock MT, Coddens S, Haezebroeck V, Fievet-Groyne F, Bixler G, Jones C, Hildreth S, Edwards KM, Messonnier NE, Tondella ML: Comparative study of different sources of pertussis toxin (PT) as coating antigens in IgG anti-PT enzyme-linked immunosorbent assays. Clin. Vaccine Immunol. 2012, 19(1):64-72.

Menzies SL, Kadwad V, Pawloski LC, Lin TL, Baughman AL, Martin M, Tondella ML, Meade BD, Pertussis Assay Working Group. Development and analytical validation of an immunoassay for quantifying serum anti-pertussis toxin antibodies resulting from Bordetella pertussis infection. Clin Vaccine Immunol. 2009;16(12):1781-1788.

Xing D, Wirsing von Konig CH, Newland P, Riffelmann M, Meade, BD, Corbel M, Gaines-Das R. Characterization of reference materials for human antiserum to pertussis antigens by an international collaborative study. Clin Vaccine Immunol. 2009;16(3):303-311.

Baughman AL, Bisgard KM, Edwards KM, Guris D, Decker MD, Holland K, Meade BD, Lynn F. Establishment of diagnostic cutoff points for levels of serum antibodies to pertussis toxin, filamentous hemagglutinin, and fimbriae in adolescents and adults in the United States. Clin Diagn Lab Immunol. 2004;11(6):1045-1053.

Pichichero ME, Edwards KM, Anderson EL, Rennels MB, Englund JA, Yerg DE, Blackwelder WC, Jansen DL, Meade BD. Safety and immunogenicity of six acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fifth dose in four- to six-year-old children. Pediatrics. 2000;105(1):e11.

Pichichero ME, Deloria MA, Rennels MB, Anderson EL, Edwards KM, Decker MD, Englund JA, Steinhoff MC, Deforest A, Meade BD. A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15- to 20-month-old children. Pediatrics. 1997;100(5):772-788.

Jansen DL, Gray GC, Putnam SD, Lynn F, Meade BD. Evaluation of pertussis in U.S. Marine Corps trainees. Clin Infect Dis. 1997;25(5):1099-1107.

Lynn F, Reed GF, Meade BD. Collaborative study for the evaluation of enzyme-linked immunosorbent assays used to measure human antibodies to Bordetella pertussis antigens. Clin Diagn Lab Immunol. 1996;3(6):689-700.

Jansen DL, Meade BD. Preparation and standardization of U.S. Standard Pertussis Vaccine, Lot No. 11. Biologicals. 1996;24(4):363-370.

Meade BD, Lynn F, Reed GF, Mink CM, Romani TA, Deforest A, Deloria MA. Relationships between functional assays and enzyme immunoassays as measurements of responses to acellular and whole-cell pertussis vaccines. Pediatrics. 1995;96(3 Pt 2):595-600.

Meade BD, Deforest A, Edwards KM, Romani TA, Lynn F, O’Brien CH, Swartz CB, Reed GF, Deloria MA. Description and evaluation of serologic assays used in a multicenter trial of acellular pertussis vaccines. Pediatrics. 1995;96(3 Pt 2):570-575.

Edwards KM, Meade BD, Decker MD, Reed GF, Rennels MB, Steinhoff MC, Anderson EL, Englund JA, Pichichero ME, Deloria MA, Deforest A. Comparison of 13 acellular pertussis vaccines: overview and serologic response. Pediatrics. 1995;96(3 Pt 2):548-557.

Mink CM, O'Brien CH, Wassilak S, Deforest A, Meade BD. Isotype and antigen specificity of pertussis agglutinins following whole-cell pertussis vaccination and infection with Bordetella pertussis. Infect Immun. 1994;62(3):1118-1120.

Meade BD, Kind PD, Ewell JB, McGrath PP, Manclark CR. In vitro inhibition of murine macrophage migration by Bordetella pertussis lymphocytosis-promoting factor. Infect Immun. 1984;45(3):718-725.